Cargando…
Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. It is rare in the post-infectious and particularly post-COVID-19 setting. Case Presentation. We present the case of a 57-year-old man who tested positi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984739/ https://www.ncbi.nlm.nih.gov/pubmed/35399911 http://dx.doi.org/10.1155/2022/1068227 |
_version_ | 1784682247931035648 |
---|---|
author | Yang, Ellen Husein, Adnan Martinez-Perez, Jose Li, Terrence |
author_facet | Yang, Ellen Husein, Adnan Martinez-Perez, Jose Li, Terrence |
author_sort | Yang, Ellen |
collection | PubMed |
description | BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. It is rare in the post-infectious and particularly post-COVID-19 setting. Case Presentation. We present the case of a 57-year-old man who tested positive for COVID-19 and experienced respiratory symptoms that completely resolved within one week. About 3 weeks after testing positive, he began experiencing acute onset anuria, followed by lower extremity paresthesia and paraparesis, which progressed to bilateral lower extremity paraplegia, complete loss of sensation of pain, temperature, vibration, and proprioception, and a T4 sensory level. He was initially diagnosed with and treated for acute inflammatory demyelinating polyradiculoneuropathy (AIDP), after which he made minimal clinical improvement. The diagnosis was shifted to longitudinally extensive transverse myelitis, and his CSF tested positive for MOG antibodies. He is being treated with a steroid regimen and extensive outpatient physical therapy. CONCLUSION: The neurologic manifestations of COVID-19 are still being uncovered. Neurologic symptoms should be included in patient education on symptom monitoring, even after recovery of respiratory illness, so that COVID-19-related CNS pathology can be urgently treated. |
format | Online Article Text |
id | pubmed-8984739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-89847392022-04-07 Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies Yang, Ellen Husein, Adnan Martinez-Perez, Jose Li, Terrence Case Rep Neurol Med Case Report BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. It is rare in the post-infectious and particularly post-COVID-19 setting. Case Presentation. We present the case of a 57-year-old man who tested positive for COVID-19 and experienced respiratory symptoms that completely resolved within one week. About 3 weeks after testing positive, he began experiencing acute onset anuria, followed by lower extremity paresthesia and paraparesis, which progressed to bilateral lower extremity paraplegia, complete loss of sensation of pain, temperature, vibration, and proprioception, and a T4 sensory level. He was initially diagnosed with and treated for acute inflammatory demyelinating polyradiculoneuropathy (AIDP), after which he made minimal clinical improvement. The diagnosis was shifted to longitudinally extensive transverse myelitis, and his CSF tested positive for MOG antibodies. He is being treated with a steroid regimen and extensive outpatient physical therapy. CONCLUSION: The neurologic manifestations of COVID-19 are still being uncovered. Neurologic symptoms should be included in patient education on symptom monitoring, even after recovery of respiratory illness, so that COVID-19-related CNS pathology can be urgently treated. Hindawi 2022-04-05 /pmc/articles/PMC8984739/ /pubmed/35399911 http://dx.doi.org/10.1155/2022/1068227 Text en Copyright © 2022 Ellen Yang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Yang, Ellen Husein, Adnan Martinez-Perez, Jose Li, Terrence Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies |
title | Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies |
title_full | Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies |
title_fullStr | Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies |
title_full_unstemmed | Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies |
title_short | Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies |
title_sort | post-covid-19 longitudinally extensive transverse myelitis with myelin oligodendrocyte glycoprotein antibodies |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984739/ https://www.ncbi.nlm.nih.gov/pubmed/35399911 http://dx.doi.org/10.1155/2022/1068227 |
work_keys_str_mv | AT yangellen postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies AT huseinadnan postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies AT martinezperezjose postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies AT literrence postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies |